Moreover, treatment with EIPA suppresses tumor growth in nude mouse xenografts of HCC cells (Yang et al., 2010), suggesting that NHE1 might be a potential therapeutic target in HCC. The gene discussed is SLC9A1; the disease is hepatocellular carcinoma.